Zscaler ThreatLabz analysis shows more than 100% growth in spyware, much of which can bypass multifactor authentication, and ...

After more than two years as HopeWest's second-ever CEO, Cassie Mitchell is leaving for a position within a newly forming ...

Military spending not only has national and global impacts, it affects the economy too. The United States spends more on the ...

VYLOY is the first and only CLDN18.2-targeted treatment approved in the U.S. for adults with advanced gastric and gastroesophageal junction cancer whose tumors are CLDN18.2 positive TOKYO, Oct. 18 ...

The Global Microfiber Cleaning Cloth Market is projected to grow at a CAGR of 24% from 2024 to 2030 , according to a new report published by Verified Market Reports®. The report reveals that the ...

Waymark, a public benefit company dedicated to improving access and quality of care in Medicaid, today published a peer-reviewed study in the New England Journal of Medicine (NEJM) Catalyst evaluating ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has approved VYLOYtm (zolbetuximab-clzb) in combination ...

If approved, patients in Europe with stage II or III HR+/HER2- early breast cancer (EBC) at high risk of recurrence, including those with node-negative disease, will be eligible f ...